Publication: The fetal occiput-spine angle measurement during first stage of labor as a predictor for vaginal delivery, a systematic review and meta-analysis
0
0
Issued Date
2025-01-01
Resource Type
ISSN
03005577
eISSN
16193997
Scopus ID
2-s2.0-105011876462
Journal Title
Journal of Perinatal Medicine
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Perinatal Medicine (2025)
Suggested Citation
Kassayanan P., Nontaprom K., Chantabal P., Suntipap M. The fetal occiput-spine angle measurement during first stage of labor as a predictor for vaginal delivery, a systematic review and meta-analysis. Journal of Perinatal Medicine (2025). doi:10.1515/jpm-2025-0220 Retrieved from: https://hdl.handle.net/20.500.14740/21238
Author(s)
Corresponding Author(s)
Other Contributor(s)
Abstract
To evaluate the diagnostic utility of the fetal occiput-spine angle (OSA) measured by transabdominal ultrasonography in predicting successful vaginal delivery (VD) during the first stage of labor. A systematic search of MEDLINE, Scopus, EMBASE databases, and Google Scholar was conducted from January 15, 2025, to February 1, 2025, following the Preferred Reporting Items for Systematic Reviews and Meta-analyses for diagnostic test accuracy guidelines. Two independent reviewers selected studies according to inclusion criteria, extracted data, and assessed risk of bias assessed by the Quality Assessment of Diagnostic Accuracy Studies-2. Six studies with 1,129 participants were included. The pooled sensitivity and specificity of OSA for predicting VD were 86 % (95 % confidence interval (CI): 73-93 %) and 80 % (95 % CI: 37-97 %), respectively. The DOR was 23.71 (95 % CI: 2.5-223.36 %). The mean OSA of women with successful VD was 10.44 wider than that of women who underwent cesarean delivery, although not significant (p=0.16). High heterogeneity (I<sup>2</sup>>88.2 %) was observed. The risk of bias was low across most domains. The fetal OSA demonstrated moderate diagnostic value in predicting successful VD. Furthermore, additional high-quality, large-scale studies with standardized cut-offs are necessary to verify its clinical utility.